Stockscreener 앱 받기
20.85
1.12%
0.23
시간 외 거래:
20.85
Lyell Immunopharma Inc 주식(LYEL)의 최신 뉴스
Lyell Immunopharma: Q1 Earnings Snapshot - WKYC
Lyell starts Phase 3 lymphoma dosing, says cash runway reaches Q3 2027 - Stock Titan
Lyell Immunopharma (NASDAQ: LYEL) cuts quarterly loss and raises equity capital - Stock Titan
Lyell Immunopharma (NASDAQ: LYEL) trims Q1 loss and advances CAR T trials - Stock Titan
Lyell Immunopharma (LYEL) Price Target Increased by 27.27% to 14.28 - MSN
LYEL SEC FilingsLyell Immunopharma, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
BofA Securities Maintains Lyell Immunopharma(LYEL.US) With Sell Rating, Maintains Target Price $12 - Moomoo
Lyell Immunopharma (NASDAQ:LYEL) Upgraded by Robert W. Baird to Strong-Buy Rating - MarketBeat
Lyell Immunopharma (NASDAQ:LYEL) Downgraded to Sell Rating by Wall Street Zen - MarketBeat
Baird initiates Lyell Immunopharma stock with outperform rating By Investing.com - Investing.com South Africa
Baird initiates Lyell Immunopharma stock with outperform rating - Investing.com
BofA reiterates Lyell Immunopharma stock Underperform on rival exit - Investing.com
BofA reiterates Lyell Immunopharma stock Underperform on rival exit By Investing.com - Investing.com India
Lyell Immunopharma climbs after reporting strong CAR T-cell therapy results - MSN
[ARS] Lyell Immunopharma, Inc. SEC Filing - Stock Titan
Lyell Immunopharma (NASDAQ: LYEL) outlines 2026 virtual meeting, board elections and pay vote - Stock Titan
Lyell Immunopharma (NASDAQ:LYEL) Shares Gap DownHere's What Happened - MarketBeat
LYEL (Lyell Immunopharma Inc.) reports far wider than expected Q4 2025 loss as shares tick modestly higher.Pro Level Trade Signals - Cổng thông tin điện tử tỉnh Tây Ninh
Euler Fund (NASDAQ: LYEL) holds 1,426,528 shares, 6.71% stake disclosed - Stock Titan
Lyell Immunopharma (LYEL) Stock: Gaining Traction? (Underperforming) 2026-04-20Retail Money Flow - Xã Thanh Hà
Lyell Immunopharma (NASDAQ:LYEL) Upgraded by Wall Street Zen to "Hold" Rating - MarketBeat
Lyell Immunopharma, Inc. (NASDAQ:LYEL) Sees Large Increase in Short Interest - MarketBeat
LYEL Earnings History & Surprises | EPS & Revenue Results | LYELL IMMUNOPHARMA INC (NASDAQ:LYEL) - ChartMill
A First Look At Lyell Immunopharma (NASDAQ:LYEL) - Seeking Alpha
[EFFECT] Lyell Immunopharma, Inc. SEC Filing - Stock Titan
Structure Therapeutics Appoints Matthew Lang, J.D. as Chief Operating Officer and General Counsel - The Manila Times
Lyell Immunopharma (NASDAQ:LYEL) Shares Down 4%Should You Sell? - MarketBeat
Lyell Immunopharma (NASDAQ:LYEL) Stock Price Up 6.9%Should You Buy? - MarketBeat
This WhiteFiber Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Friday - Sahm
Needham initiates coverage of Lyell Immunopharma (LYEL) with buy recommendation - MSN
Lyell Immunopharma, Inc. (NASDAQ:LYEL) Receives Consensus Recommendation of "Hold" from Analysts - MarketBeat
Needham & Company LLC Begins Coverage on Lyell Immunopharma (NASDAQ:LYEL) - MarketBeat
Is Lyell Immunopharma (LYEL) Stock Attractive Now | Price at $23.72, Down 0.55%Pro Trader Recommendations - Newser
Lyell Immunopharma (NASDAQ:LYEL) Cut to Strong Sell at Zacks Research - Defense World
Signal Recap: Will Lyell Immunopharma Inc outperform tech stocksQuarterly Performance Summary & Free Real-Time Market Sentiment Alerts - baoquankhu1.vn
Lyell Immunopharma Announces Participation in 25th Annual Needham Virtual Healthcare Conference - Sahm
Lyell Immunopharma to Present at 25th Annual Needham Virtual Healthcare Conference - National Today
Cancer drug developer Lyell will webcast a management presentation Apr. 14 - Stock Titan
Head to Head Analysis: Lyell Immunopharma (NASDAQ:LYEL) & Mangoceuticals (NASDAQ:MGRX) - Defense World
Lyell Immunopharma registers 1.95M shares for resale (NASDAQ: LYEL) - Stock Titan
Lyell Immunopharma (NASDAQ:LYEL) Trading Up 9.2%Time to Buy? - MarketBeat
US Stocks Recap: How sensitive is Lyell Immunopharma Inc to inflation2026 Risk Factors & Reliable Entry Point Alerts - baoquankhu1.vn
Lyell Immunopharma (NASDAQ:LYEL) Lowered to Sell Rating by Wall Street Zen - MarketBeat
LYEL Technical Analysis & Stock Price Forecast - Intellectia AI
Lyell Immunopharma: Strong Early CAR-T Data, And Now A More Measured Bet (NASDAQ:LYEL) - Seeking Alpha
H.C. Wainwright reiterates Lyell Immunopharma stock rating at buy By Investing.com - Investing.com Canada
Is Lyell Immunopharma Inc impacted by rising rates2026 Volume Leaders & Low Volatility Stock Suggestions - baoquankhu1.vn
Lyell Immunopharma (LYEL) grants CFO 140,000 stock options - Stock Titan
Lyell Immunopharma (LYEL) CFO Shah identified as insider in Form 3 - Stock Titan
Lyell Immunopharma, Inc. $LYEL Shares Acquired by Foresite Capital Management V LLC - MarketBeat
Citizens reiterates Lyell Immunopharma stock rating on trial progress By Investing.com - ca.investing.com
1.77%
0.25%
자본화:
|
볼륨(24시간):